Dr Vamshi Krishna | Talapro-2: Final Overall Survival In Propel

Dr Vamshi Krishna | TALAPRO-2: Final overall survival (OS) in PROpel

CRSF - Cancer Research and Statistic Foundation

Fred Saad, ESMO 2022: Phase III PROpel trial of abiraterone+olaparib in prostate cancer

Touch Medical Media

PROpel trial

European Association of Urology

HALL B : How do I treat? - Clinical Guidelines Updates and Difficult situations management.

Dr Sachin Gupta

Survival results from STAMPEDE, radiotherapy for prostate cancer

Prostate Cancer Prognosis and Survival

PROCURE - Cancer Prostate

Overview and advances in tumor treatment fields (TTFields)

Immunotherapy for Castration Resistant Prostate Cancer

Grand Rounds in Urology

SABCS 2013: NeoALTTO, breast cancer with pathologic complete response, event-free & overall survival

Overall Survival with Sipuleucel-T in Patients Treated for Advanced Prostate Cancer

Grand Rounds in Urology

Renal Artery Injury during Robotic (SSi Mantra) Partial Nephrectomy

Preeti Urology & Kidney Hospital

Dr. Eric P. Winer on Pathologic Complete Response and Disease Free Survival in Breast Cancer

Targeted Oncology

Gastric Cancer - Treatment & Survival | @MedvarsityOnlineLtd

Medvarsity Online Limited

ARASENS: Will combining different treatments improve prostate cancer survival?

Overall Survival With Palbociclib Plus Fulvestrant

Precision medicine to extend lives of advanced prostate cancer patients

ProstateCancerCanada

TAS-102 plus bevacizumab vs. TAS-102 alone for previously treated metastatic esophagogastric cancer

Dr. Arkenau on Survival Data With TAS-102 in Gastric Cancer